![Ashley Magargee: Fortunate to have leading computational biology experts like Aviv Regev advancing our understanding of cancer like never before](https://oncodaily.com/pub/uploads/2024/04/Aviv-Regev-and-Ashley-Magargee.jpg)
Ashley Magargee: Fortunate to have leading computational biology experts like Aviv Regev advancing our understanding of cancer like never before
Ashley Magargee, Chief Executive Officer at Genentech, shared on LinkedIn:
“We’re fortunate to have leading computational biology experts like Aviv Regev advancing our understanding of cancer like never before.
At AACR24, she shared the importance of connection in drug discovery – from the data to the lab to the clinic. AI is fueling this connection.
I’m excited about the strides we’ve made at Genentech using AI across many parts of our organization, including applying it to accelerate drug discovery and development.
I’m looking forward to seeing how AI, computation, data science and digital technology continue to enhance our ability to improve patient care and bring innovative medicines to patients faster.”
View additional information.
Source: Ashley Magargee/LinkedIn
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.